Sphere Fluidics, has closed a $40 million (circa £30 million) investment round. 

Pharmacierge, the healthtech company that offers same-day prescription medicine delivery in London and next day delivery throughout the UK, has raised £1.25m from a number of leading clinicians and angel investors.  Investors include Alex Chesterman OBE, founder of Cazoo and Zoopla and Simon Franks, who co-founded Lovefilm. In a show of confidence from the medical profession, many practitioner users have also invested in the round, 

Imophoron, a developer of a novel, next generation rapid-response vaccine platform, ADDomer(TM), to combat present and future infectious diseases, has secured £4 million in an oversubscribed fundraising round. 

Entia, a medical technology business, which recently announced a commercial partnership with Pfizer UK, raised $12 million earlier in the year in a funding round co-led by UK growth capital investor, BGF and growth fund manager, Parkwalk, with participation from existing seed investor Sussex Place Ventures.

Stim OxyGen, an innovative cancer treatment technology company, has been named as the overall winner of the 2021 Northern Ireland INVENT Awards.

Sanome, a European health start-up, has raised £2m as its first round of funding from a number of leading UK and European HealthTech specialist investors. The round was led by Heal Capital, with participation from Crista Galli Ventures, Selvedge Ventures, o2h Ventures, Meltwind and a number of high-profile angels including David Cleevely and Pam Garside.

Poor mental health has grown to be a global crisis, with 1 in 5 people experiencing common mental health symptoms like anxiety and depression in any given year¹. In the search for more effective and accessible treatments for mental wellness, renewed scientific and commercial interest in psychedelic medicine is now leading to rapid advancements in psychedelic models of care for mental health. Founders Factory and Woven Science have announced a unique partnership to invest in groundbreaking startups that have the ability to redefine mental healthcare and build new solutions that make sustainable well-being accessible to all.

Doccla, the healthtech startup pioneering virtual ward technology to ease pressure on hospitals, has secured £2.4m in an oversubscribed seed round, led by Giant Ventures, the leading purpose-driven venture firm, and early-stage technology VC, Speedinvest. Doccla is reimagining hospital care using innovative remote medical monitoring to deliver safe, effective care from the home. The investment will supercharge the startup’s ambition to make virtual hospitals a core part of modern healthcare.

contextflow, a leading provider of artificial intelligence for medical image analysis, has announced a EUR 6.7 Million Series A funding round. A second closing included an additional EUR 2 Million from new co-investor Peak Pride Management GmbH, HPH (Hans Peter Haselsteiner) Start-up Unit and current investor APEX Ventures with its “APEX Best in Class” fund. A first closing was led by B&C Innovation Investments GmbH (BCII) and included participation from new co-investor TTIP Beteiligungs GmbH and current investors APEX Ventures, Crista Galli Ventures, IST cube, Nina Capital and Novacapital.

Elvie, the global health and lifestyle brand developing iconic products for women, has announced an extension of its Series C funding with a further £12.7m ($17.5m) investment.  This investment is an extension to the initial Series C funding announced in July 2021 - and takes Elvie’s total Series C to £70m ($97m).  Founded in 2013 by CEO Tania Boler, Elvie brings together a team of world-class engineers, designers and business minds to develop extraordinary products that improve women’s lives

Abtrace, a healthtech start-up which uses machine learning to transform how chronic and long-term health conditions are detected, monitored and treated, has raised £2.1m of seed funding in a round led by Faber and joined by Ganexa Capital.

As dentists worldwide begin to tackle the backlog of patients whose tooth decay may have worsened during the Covid-19 pandemic*, Edinburgh-based dental technology company, Calcivis, is preparing for a US launch with a restructuring of its board and the successful completion of its latest funding round.  Calcivis has developed the world’s first biotechnology-based dental imaging system and has been part of the portfolio of the Scottish business angel investment syndicate, Archangels, since 2012.